In a new publication in Integrative Biology, Ricke lab collaborator, Dr. David Beebe, describes a series of assays, using a reconfigurable microscale assay platform (i.e. Stacks), which allows the study of immune cell infiltration in vitro with spatiotemporal …
News
Dr. William Ricke awarded a $2M R01 grant from NIDDK titled “Estrogen Pathways in the Development of Prostatic Fibrosis and Lower Urinary Tract Dysfunction”
Dr. William Ricke has been awarded a R01 grant from NIDDK titled “Estrogen Pathways in the Development of Prostatic Fibrosis and Lower Urinary Tract Dysfunction”. The $2 million grant, funded from 4/1/2021-3/31/2025, aims to establish estrogen …
Dr. Petra Popovics’ abstract selected as Best Abstract in Basic Science category for 6th Annual DUKE KURe Symposium
Congratulations to Dr. Petra Popovics, PhD, whose abstract “Loss of Osteopontin Leads to the Resolution of E.Coli-Induced Prostatic Inflammation and Fibrosis” was selected as the best abstract in the Basic Science category for the 6th Annual …
Ricke Lab and Collaborators Publish a New Approach for Characterizing Mouse Urinary Pathophysiologies
In a new publication in Physiological Reports, UW O’Brien Center researchers demonstrate a new approach for characterizing mouse urinary pathophysiologies using Void Spot Assay (VSA) technology. The findings support continued use of VSA for etiologic …
Combatting Opioid Misuse Through Improved Post-Operative Pain Management
The increased prescribing of opioid medications has led to a widespread misuse of both prescription, and non-prescription opioids. How can surgeons assure that their patients are not at risk of misusing their prescribed medications? Tudor …
Ricke lab discovers a novel mechanism and possible treatment for castration resistant prostate cancer
Dr. William Ricke’s laboratory has discovered a potential method to treat castration resistant prostate cancer (CRPC), by targeting a novel molecular mechanism involving RNA-binding protein. Drs. Ricke, Vellky, and colleagues have described DDX3 (DEAD-box helicase 3 …
Ricke Lab welcomes new graduate student, Han Zhang
The Ricke Lab is pleased to welcome our newest lab member, Han Zhang, a UW School of Pharmacy graduate student. Han will be studying hormone resistance and bioinformatics in relation to prostate disease. Welcome, Han!
Christian Ortiz Hernandez, PhD candidate, awarded a NIDDK U54 supplement to study the role of estrogens in the development of prostate fibrosis and LUTD
We are proud to announce that Christian Ortiz Hernandez, PhD candidate in Dr. Will Ricke’s lab, has been awarded a NIDDK U54 supplemental grant to study the role of estrogens in inducing prostate fibrosis and associated lower …
Dr. Debra Garvey awarded a NIEHS R01 supplement to study estrogen receptor alpha in relation to the development of LUTD
Congratulations to Dr. Debra Garvey, Research Associate/Post-doc in Dr. Will Ricke’s lab, for being awarded a NIEHS R01 supplemental grant to study estrogen receptor alpha in relation to the development of lower urinary tract dysfunction under the …
Thank you, Doctors – National Doctors’ Day
Throughout the past year, our doctors have faced challenges unlike any they have seen before. During this unprecedented time in medicine, our outstanding physicians have showed up for their community, ready to work and care …